LinkedIn facebook twitter youtube
News archive
Recent news


Myeloma Patients Europe’s (MPE) 2022 Year in Review is snapshot of the major accomplishments from the past year.


In this report, you’ll read about MPE’s activities and key accomplishments to empower our members, educate the patient community, shape drug development, address gaps in patient evidence, and increase access to innovative treatments. We look forward to the continued growth and evolution of these initiatives in the years ahead as we continue our efforts to improve patient treatment, care, and access across Europe.
MPE extends a heartfelt thank you to our members, Medical Advisory Committee, sponsors, and stakeholders for your ongoing dedication and inspiration. The milestones we reached this year would not have been possible without your partnership, and we share these achievements with each of you.


Click here to read 2022: Year in Review.

Recent news

» Daratumumab approved for first line treatment in Israel

» Join MPE's webinar on doctor and patients’ perspectives on myeloma CAR-T

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy